Literature DB >> 2791220

Metabolic oxidation of glucose during early myocardial reperfusion.

B Renstrom1, S H Nellis, A J Liedtke.   

Abstract

We have previously studied the relation between long-chain fatty acid and pyruvate metabolism in reperfused myocardium and noted a rapid return of fatty acid oxidation to at least preischemic values accompanied by a marked decrease in pyruvate oxidation. The purpose of the present report is to further characterize carbohydrate metabolism during reflow by describing rates of glucose oxidation using [6-14C]glucose. Oxidative performance was determined with and without preserved fatty acid utilization; the latter condition was effected by oxfenicine, which inhibits palmitoylcarnitine transferase I. In the main protocol, two groups of working swine hearts (n = 18) were perfused aerobically for 30 minutes, rendered regionally ischemic (-60 delta % in anterior descending coronary flow) for 45 minutes, and reperfused at control flows for a final 50 minutes of perfusion. An emulsion of Intralipid with heparin was administered systemically throughout the studies to augment serum fatty acids (average fatty acid values, 1.05 +/- 0.05 mumol/ml for both groups). Serum glucose was monitored and maintained at or about 100 mg/dl with additional infusions of glucose as needed. Oxfenicine (33 mg/kg) was administered systemically by bolus injection at time 0 and 60 minutes of perfusion in nine animals. Decreased mechanical performance, that is, stunning, during reflow was evident in both groups (-50 delta % in regional systolic shortening, p less than or equal to 0.05 compared with aerobic values in the control group, and -32 delta %, p less than or equal to 0.05 compared with aerobic values in treated hearts).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2791220     DOI: 10.1161/01.res.65.4.1094

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  11 in total

Review 1.  Hibernating myocardium.

Authors:  R Schulz; G Heusch
Journal:  Heart       Date:  2000-12       Impact factor: 5.994

Review 2.  Myocardial fatty acid oxidation during ischemia and reperfusion.

Authors:  R Lerch; C Tamm; I Papageorgiou; R H Benzi
Journal:  Mol Cell Biochem       Date:  1992-10-21       Impact factor: 3.396

Review 3.  Free fatty acid metabolism during myocardial ischemia and reperfusion.

Authors:  S C Hendrickson; J D St Louis; J E Lowe; S Abdel-aleem
Journal:  Mol Cell Biochem       Date:  1997-01       Impact factor: 3.396

4.  Metabolic imaging: what are the challenges?

Authors:  L H Young; P H McNulty
Journal:  J Nucl Cardiol       Date:  1994 Mar-Apr       Impact factor: 5.952

Review 5.  Adjustments in competitive substrate utilization in stunned myocardium during early reperfusion.

Authors:  B Renstrom; A J Liedtke
Journal:  Basic Res Cardiol       Date:  1995 Jul-Aug       Impact factor: 17.165

Review 6.  Energy metabolism in the normal and failing heart: potential for therapeutic interventions.

Authors:  William C Stanley; Margaret P Chandler
Journal:  Heart Fail Rev       Date:  2002-04       Impact factor: 4.214

Review 7.  Glucose and glycogen utilisation in myocardial ischemia--changes in metabolism and consequences for the myocyte.

Authors:  L M King; L H Opie
Journal:  Mol Cell Biochem       Date:  1998-03       Impact factor: 3.396

8.  The liver isoform of carnitine palmitoyltransferase I is activated in neonatal rat cardiac myocytes by hypoxia.

Authors:  D Wang; Y Xia; L M Buja; J B McMillin
Journal:  Mol Cell Biochem       Date:  1998-03       Impact factor: 3.396

Review 9.  Cardiac efficiency.

Authors:  J D Schipke
Journal:  Basic Res Cardiol       Date:  1994 May-Jun       Impact factor: 17.165

Review 10.  Oxidative substrate metabolism during postischemic reperfusion.

Authors:  R Lerch
Journal:  Basic Res Cardiol       Date:  1993 Nov-Dec       Impact factor: 17.165

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.